Shriprasad Deshpande, MD
Director, Advanced Cardiac Therapies and Director, Heart Transplant Program
National Children’s Hospital
Washington, DC USA
Dr. Deshpande's research focuses on the use of cell-free DNA in
monitoring transplant recipients for rejection. He explains that
cell-free DNA, released when cells break down, can be detected in
the bloodstream and used as a non-invasive screening tool to assess
the health of transplanted organs.